CANDACE MALONE: Open Payments
NPI 1023550894 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$928 in 49 payments from 15 companies in 2025. Trend: 2023 $1,738 · 2024 $1,446 · 2025 $928
Food & beverage: $928
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $176 |
| Lilly USA, LLC | 6 | $113 |
| Dexcom, Inc. | 3 | $92 |
| Astellas Pharma US Inc | 4 | $84 |
| Novo Nordisk Inc | 5 | $73 |
| Amgen Inc. | 4 | $66 |
| ABBVIE INC. | 3 | $63 |
| Eisai Inc. | 2 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
Products named: NURTEC ODT, Dexcom G6 Transmitter, Veozah, MOUNJARO, PREVNAR 20, Ozempic, Leqembi, REXULTI.
Industry payments across SC — which companies pay providers there.
